|
|
|
|
| LEADER |
05146nam a2200637 4500 |
| 001 |
on1105557047 |
| 003 |
OCoLC |
| 005 |
20200326101202.0 |
| 006 |
m o d |
| 007 |
cr cnu|||unuuu |
| 008 |
190624s2019 mau ob 000 0 eng d |
| 040 |
|
|
|a N$T
|b eng
|e rda
|e pn
|c N$T
|d N$T
|d OPELS
|d EBLCP
|d OCLCF
|d YDX
|d DKU
|d U3G
|d UKAHL
|d OCLCQ
|d GrThAP
|
| 019 |
|
|
|a 1105857818
|a 1122761502
|a 1125778919
|
| 020 |
|
|
|a 9780128173169
|q (electronic bk.)
|
| 020 |
|
|
|a 0128173165
|q (electronic bk.)
|
| 020 |
|
|
|a 9780128167588
|
| 020 |
|
|
|a 0128167580
|
| 035 |
|
|
|a (OCoLC)1105557047
|z (OCoLC)1105857818
|z (OCoLC)1122761502
|z (OCoLC)1125778919
|
| 050 |
|
4 |
|a RM30
|b .A4eb v. 84
|
| 072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
| 072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
| 082 |
0 |
4 |
|a 616.8498
|2 23
|
| 245 |
0 |
0 |
|a Pharmacology of restless legs syndrome (RLS) /
|c edited by Stefan Clemens, Imad Ghorayeb, S.J. Enna, Lynn Lecount.
|
| 250 |
|
|
|a First edition.
|
| 264 |
|
1 |
|a Cambridge, MA, United States :
|b Academic Press,
|c 2019.
|
| 300 |
|
|
|a 1 online resource
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 347 |
|
|
|a data file
|2 rda
|
| 490 |
1 |
|
|a Advances in pharmacology ;
|v volume eighty four
|
| 504 |
|
|
|a Includes bibliographical references.
|
| 588 |
|
|
|a Online resource; title from PDF title page (EBSCO, viewed June 26, 2019).
|
| 505 |
0 |
0 |
|g Section I:
|t Adenosine mechanisms and hypersensitive corticostriatal terminals in restless legs syndrome. Rationale for the use of inhibitors of adenosine transport /
|r Sergi Ferré, César Quiroz, William Rea, Xavier Guitart, Diego García-Borreguero --
|g 2.
|t D3 receptor agonist efficacy in restless legs syndrome /
|r Francesca Casoni, Andrea Galbiati, Luigi Ferini-Strambi --
|g 3.
|t The heterotetrameric structure of the adenosine A1-dopamine D1 receptor complex: Pharmacological implication for restless legs syndrome /
|r Antoni Cortés, Verònica Casadó-Anguera, Estefanía Moreno, Vicent Casadó --
|g 4.
|t D3 and D1 receptors: The Yin and Yang in the treatment of restless legs syndrome with dopaminergics /
|r Stefan Clemens, Imad Ghorayeb --
|g 5.
|t The neurophysiology of hyperarousal in restless legs syndrome: Hints for a role of glutamate/GABA /
|r Giuseppe Lanza, Raffale Ferri.
|
| 505 |
8 |
0 |
|g Section II:
|t Disease models/genetics:
|g 6.
|t Iron uptake at the blood-brain barrier is influenced by sex and genotype /
|r Quinn W. Wade, Brian Chiou, James R. Connor --
|g 7.
|t Caenorhabditis elegans and its applicability to studies on restless legs syndrome /
|r Pan Chen, Omamuyovwi Meashack Ijomone, Kun He Lee, Michael Aschner --
|g 8.
|t Role of MEIS1 in restless legs syndrome: From GWAS to functional studies in mice /
|r Aaro V. Salminen, Daniel D. Lam, Juliane Winkelmann.
|
| 505 |
8 |
0 |
|g Section III:
|t Treatments and treatment complications:
|g 9.
|t Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome /
|r Vivian Wanner, Celia Garcia Malo, Sofía Romero, Irene Cano-Pumarega, Diego García-Borreguero --
|g 10.
|t Idiopathic restless legs syndrome treatment : progress and pitfalls? /
|r Imad Ghorayeb --
|g 11.
|t Treatment of pediatric restless legs syndrome /
|r Lourdes DelRosso, Oliviero Bruni --
|g 12.
|t Pharmacological treatments of augmentation in restless legs syndrome patients /
|r Claudia Trenkwalder, Walter Paulus.
|
| 520 |
|
|
|a 'Pharmacology of Restless Legs Syndrome (RLS), ' Volume 84 in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field on essential topics, with this volume presenting chapters on Targeting the adenosinergic system in Restless Legs Syndrome, Assessing iron uptake mechanisms in the brain: impact of gender and genotype, Pharmacological treatments of RLS in augmentation, C. elegans and its applicability to studies on RLS, The neurophysiology of hyperarousal in RLS: hints for a role of glutamate/GABA, Treatment management and options in RLS patients, Pharmacological responsiveness of Periodic Legs Movements during Sleep, and more. --
|c Provided by publisher.
|
| 650 |
|
0 |
|a Restless legs syndrome.
|
| 650 |
|
0 |
|a Leg
|x Effect of drugs on.
|
| 650 |
|
7 |
|a HEALTH & FITNESS
|x Diseases
|x General.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Clinical Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Diseases.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Evidence-Based Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a MEDICAL
|x Internal Medicine.
|2 bisacsh
|
| 650 |
|
7 |
|a Restless legs syndrome.
|2 fast
|0 (OCoLC)fst01095982
|
| 655 |
|
4 |
|a Electronic books.
|
| 700 |
1 |
|
|a Clemens, Stefan,
|e editor.
|
| 700 |
1 |
|
|a Ghorayeb, Imad,
|e editor.
|
| 700 |
1 |
|
|a Enna, S. J.,
|e editor.
|
| 700 |
1 |
|
|a Lecount, Lynn,
|e editor.
|
| 776 |
0 |
8 |
|i Print version:
|t Pharmacology of restless legs syndrome (RLS).
|b First edition.
|d Cambridge, MA, United States : Academic Press, 2019
|z 0128167580
|z 9780128167588
|w (OCoLC)1078566982
|
| 830 |
|
0 |
|a Advances in pharmacology (San Diego, Calif.) ;
|v v. 84.
|
| 856 |
4 |
0 |
|3 ScienceDirect
|u https://www.sciencedirect.com/science/bookseries/10543589/84
|z Full Text via HEAL-Link
|
